Arca biopharma to present at the q4 virtual investor summit on november 17th

Westminster, colo., nov. 09, 2021 (globe newswire) -- arca biopharma, inc. (nasdaq: abio), a biopharmaceutical company applying a precision medicine approach to developing genetically targeted therapies for cardiovascular diseases, today announced that tom keuer, chief operating officer, will present at the q4 virtual investor summit being held november 16-17, 2021.
ABIO Ratings Summary
ABIO Quant Ranking